Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018

JAMA - Journal of the American Medical Association

Volumn 321, Issue 16, 2019, Pages 1627-1629

  Hernandez, Inmaculada ^a   Good, Chester B ^b   Shrank, William H ^b,c   Gellad, Walid F ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c HUMANA INC   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSIMILAR AGENT; INSULIN; INSULIN DEGLUDEC; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLARGINE PLUS LIXISENATIDE; LONG ACTING INSULIN;

CONCENTRATION (PARAMETER); DRUG APPROVAL; DRUG MARKETING; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MEDICAID; PRIORITY JOURNAL; TREND STUDY; COST CONTROL; DRUG COST; ECONOMICS; REIMBURSEMENT; TRENDS; UNITED STATES;

BIOSIMILAR PHARMACEUTICALS; COST SAVINGS; DRUG COSTS; DRUG UTILIZATION; HUMANS; INSULIN GLARGINE; INSULIN, LONG-ACTING; INSURANCE, HEALTH, REIMBURSEMENT; MEDICAID; UNITED STATES;

EID: 85063419105     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2019.2990     Document Type: Letter

References (6)

1. Luo J, Avorn J, Kesselheim AS. Trends in Medicaid reimbursements for insulin from 1991 through 2014. JAMA Intern Med. 2015; 175 (10): 1681-1686. doi: 10.1001/jamainternmed.2015.4338 26301721
2. Hua X, Carvalho N, Tew M, Huang ES, Herman WH, Clarke P. Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013. JAMA. 2016; 315 (13): 1400-1402. doi: 10.1001/jama.2016.0126 27046369
3. Greene JA, Riggs KR. Why is there no generic insulin? historical origins of a modern problem. N Engl J Med. 2015; 372 (12): 1171-1175. doi: 10.1056/NEJMms1411398 25785977
4. US Food and Drug Administration Center for Drug Evaluation and Research. Approval package for Basaglar. https://www.accessdata.fda.gov/drugsatfda-docs/nda/2015/205692Orig1s000Approv.pdf. Accessed January 7, 2019.
5. Centers for Medicare & Medicaid Services. Medicaid drug rebate program. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html. Accessed September 25, 2018.
6. San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. Assessment of price changes of existing tumor necrosis factor inhibitors after the market entry of competitors. JAMA Intern Med. 2019. doi: 10.1001/jamainternmed.2018.7656 30776053